Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.
Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check16 days agoChange DetectedNew study details have been added, including contact information for study personnel and specific eligibility criteria for patients with newly diagnosed multiple myeloma, while several previous criteria and a serious adverse event review have been removed.SummaryDifference28%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check51 days agoChange DetectedThe study has been updated to version v2.10.0, indicating a new revision from the previous version v2.9.7.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check72 days agoChange DetectedDifference0.0%
Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.